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ABSTRACT
Introduction Heavy goods vehicle (HGV) drivers exhibit 
higher than nationally representative rates of obesity, 
and obesity- related comorbidities, in comparison to other 
occupational groups. Their working environments are not 
conducive to a healthy lifestyle, yet there has been limited 
attention to health promotion efforts. We have developed 
a Structured Health Intervention For Truckers (the SHIFT 
programme), a multicomponent, theory- driven, health- 
behaviour intervention targeting physical activity, diet and 
sitting in HGV drivers. This paper describes the protocol of 
a cluster randomised controlled trial designed to evaluate 
the effectiveness and cost- effectiveness of the SHIFT 
programme.
Methods and analysis HGV drivers will be recruited 
from a logistics company in the UK. Following baseline 
measurements, depots (clusters) will be randomised to 
either the SHIFT intervention or usual- care control arm 
(12 clusters in each, average cluster size 14 drivers). 
The 6- month SHIFT intervention includes a group- based 
interactive 6- hour education session, worksite champion 
support and equipment provision (including a Fitbit and 
resistance bands/balls to facilitate a ‘cab workout’). 
Objectively measured total daily physical activity (steps/
day) will be the primary outcome. Secondary outcomes 
include: objectively measured light- intensity physical 
activity and moderate- to- vigorous physical activity, sitting 
time, sleep quality, markers of adiposity, blood pressure 
and capillary blood markers (glycated haemoglobin, low- 
density lipoprotein- cholesterol, high- density lipoprotein- 
cholesterol). Self- report questionnaires will examine fruit 
and vegetable intake, psychosocial and work outcomes 
and mental health. Quality of life and resources used 
(eg, general practitioner visits) will also be assessed. 
Measures will be collected at baseline, 6 and 12 months 
and analysed according to a modified intention- to- treat 
principle. A full process evaluation and cost- effectiveness 
analysis will be conducted.
Ethics and dissemination Ethical approval was obtained 
from the Loughborough University Ethics Approvals Sub- 
Committee (reference: R17- P063). Study findings will 
be disseminated through publications in research and 
professional journals, through conference presentations 
and to relevant regional and national stakeholders via 
online media and at dissemination events.
Trial registration number ISRCTN10483894.
InTRoduCTIon
Long- distance heavy goods vehicle (HGV) 
drivers are exposed to a multitude of health- 
related risk factors associated with their occu-
pation; as a result, lorry driving has been 
identified as one of the most hazardous 
working professions.1 2 Drivers’ working 
environment provides limited opportuni-
ties for a healthy lifestyle and unhealthy 
lifestyle behaviours, such as a lack of phys-
ical activity, prolonged periods of sedentary 
behaviour (sitting), poor diet, a high preva-
lence of smoking, high volumes of alcohol 
Strengths and limitations of this study
 ► To our knowledge, this is the first randomised 
controlled trial to examine the impact of a multi-
component intervention targeting individual and en-
vironmental barriers faced by heavy goods vehicle 
drivers to lead a healthy lifestyle.
 ► The trial will involve a full process evaluation and an 
economic evaluation.
 ► The primary outcome, physical activity, will be ob-
jectively measured.
 ► Sustainability of the intervention will be examined 
at 6 months follow- up, following completion of the 
intervention.
 ► Due to the nature of the intervention, participants 
will not be blinded to their treatment arm, and there 
is a risk that the secondary outcome self- report 
measures may be susceptible to reporting bias.
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consumption and irregular sleeping patterns are wide-
spread among this occupational group.2–5 Furthermore, 
long and variable working hours, including shift work, 
and tight delivery schedules within the logistics and trans-
port industry contribute to psychological stress and sleep 
deprivation,6 which can lead to metabolic disturbances 
and further promote the uptake of unhealthy behavioural 
choices.2 5–8
Long- distance drivers exhibit higher than nationally 
representative rates of obesity, with observational data 
from a sample of HGV drivers from the UK demonstrating 
that 84% were overweight or obese, compared with 75% 
of males aged 45–54 years reported to be overweight/
obese nationally.9 Similar data have been reported from 
US HGV drivers.2 10 The high rates of overweight and 
obesity in HGV drivers elevates their risk of numerous 
chronic diseases and conditions, including cardiovas-
cular disease, type 2 diabetes, obstructive sleep apnoea 
and musculoskeletal disorders.1 2 10–13
To compound the high- risk health profile observed in 
long- distance drivers nationally and internationally,1 2 10–12 
the driver population in the UK (n=~300 000) has been 
identified as an ageing workforce (mean age: 48 years).14 
A recent parliamentary report has highlighted the ‘demo-
graphic time bomb’ the UK logistics industry is currently 
facing and the health impact of an ageing, at- risk, work-
force ‘driving a vehicle often referred to as ‘a 40- tonne 
missile’’.15 The UK logistics sector is also experiencing 
a short- fall in HGV drivers, with barriers to recruitment 
including the lack of roadside facilities, medical concerns 
and long hours of work.16 Recommendations on how 
to address this shortfall and attract younger employees 
to the sector include increasing awareness within the 
industry of the need to address driver health risks and 
health behaviours.15
A systematic review17 of health promotion interventions 
in truck drivers, including only eight studies, observed 
that the interventions generally led to improvements in 
health and health behaviours. However, it was concluded 
that the strength of the evidence was limited due to poor 
study designs, with no control groups, small samples and 
no or limited follow- up periods.17 Since the publication 
of the systematic review, recent studies have examined the 
impacts of a weight loss intervention in US HGV drivers18 
and a smartphone application on physical activity and 
diet in Australian HGV drivers.19 While positive findings 
were observed, the studies were limited by relatively small 
samples and no comparison groups.
We have developed a Structured Health Intervention 
For Truckers (the SHIFT programme), a multicom-
ponent, theory- driven, health behaviour intervention 
designed to promote positive lifestyle changes in relation 
to physical activity, diet and sitting in HGV drivers. This 
intervention has been informed by extensive stakeholder 
engagement, including a qualitative study exploring the 
perceived barriers to healthy lifestyle behaviours in HGV 
drivers,7 an observational study exploring lifestyle health- 
related behaviours in HGV drivers and markers of health3 
and a pre- post pilot intervention20 with full process evalua-
tion.21 Initial pre- post testing of the intervention revealed 
the SHIFT programme lead to favourable changes in 
physical activity and some markers of health.20 This 
protocol paper describes a study which will build on our 
earlier work and generate new knowledge on the effec-
tiveness and cost- effectiveness of the SHIFT programme, 
evaluated using a cluster randomised controlled trial 
(RCT) design with immediate and extended follow- up. 
Specifically, we will examine the impact of the SHIFT 
programme on physical activity, sedentary behaviour, 
fruit and vegetable intake, adiposity, sleep duration and 
quality, risk factors for cardiometabolic disease, psycho-
social outcomes and mental health in a sample of HGV 
drivers.
Study aim and objectives
The aim of this study is to evaluate the effectiveness 
and cost- effectiveness of the SHIFT programme using a 
cluster RCT.
Primary objective
To investigate the impact of the SHIFT programme, 
compared with usual care, on objectively measured 
physical activity (expressed as steps/day) at 12 months 
follow- up.
Secondary objectives
To investigate the impact of the SHIFT programme, 
compared with usual care, at 12 months follow- up on:
1. time spent in light and moderate- to- vigorous physical 
activity (MVPA);
2. sitting time;
3. measures of adiposity (body mass index (BMI), per 
cent body fat, waist- to- hip ratio, neck circumference);
4. blood pressure;
5. cardiometabolic risk markers (eg, glycated haemoglo-
bin (HbA1c), total cholesterol, low- density lipoprotein- 
cholesterol (LDL- C), high- density lipoprotein- 
cholesterol (HDL- C));
6. fruit and vegetable intake;
7. sleep;
8. cognitive function and psychophysiological reactivity;
9. psychosocial variables and mental health (eg, anxiety 
and depression, work engagement, job performance 
and satisfaction, presenteeism, sickness absence, 
health- related quality of life and driving- related safety 
behaviour).
We will also conduct a full process evaluation (secondary 
objective 10) and a full economic evaluation (secondary 
objective 11).
METhodS And AnAlySIS
design
The design of this study is based on guidance from the 
UK Medical Research Council for developing and eval-
uating complex interventions,22 and this protocol paper 
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has been prepared following the recommendations 
within the Standard Protocol Items for Randomised Trials 
statement.23 This is a workplace two- armed 12- month 
cluster RCT, which will incorporate an internal pilot, and 
include both economic and process evaluations. Clusters 
(different worksites/depots within the same company) 
will be randomised, following the completion of baseline 
measurements, to receive either the ‘SHIFT programme’ 
or usual care condition. The impact of the intervention 
will be assessed at 6 and 12 months after randomisation. 
Figure 1 shows the overall trial design.
Setting
This research will take place within the worksite setting 
of a major international logistics and transport company. 
The logistics and posts sector is worth approximately £55 
billion to the UK economy and currently employs approx-
imately 1.7 million people. Driving is a fundamental occu-
pation within this industry, and drivers and warehouse 
workers make up the majority of the workforce within the 
industry.15
depot recruitment and exclusion criteria
Depots will be included in the study if they contain at 
least 20 long- distance HGV drivers (see ‘Sample size’ 
section). Depots containing HGV drivers who make many 
delivery stops, for example, drivers who deliver consumer 
goods to domestic customers throughout the day will be 
excluded. For logistical reasons, depots located within the 
Midlands region of the UK will be recruited. Our partner 
company has approximately 40 sites, containing approx-
imately 1700 HGV drivers within this region. These sites 
are a similar size, and have a similar variation in size, 
to the company’s national- level data. During recruit-
ment, depots will be informed that they will have a 50% 
chance of being randomised to a current practice control 
condition.
Participant recruitment and exclusion criteria
All HGV drivers within participating depots will be eligible 
to participate, unless they meet the following exclusion 
criteria: suffering from clinically diagnosed cardiovascular 
disease, or mobility limitations that prevent them from 
increasing their daily activity levels, haemophilia or have 
any blood- borne viruses. Posters advertising the study will 
be placed in participating depots for up to 4 weeks prior 
to the scheduling of baseline measurements. In addition, 
all drivers within participating depots will receive a letter 
and participant information sheet informing them of the 
study. Following the distribution of the study marketing 
material, researchers will visit participating depots for 1–2 
days to enable interested drivers to ask any questions about 
the study before signing up. On completion of these visits, 
the researchers will provide a list of drivers’ names who 
have agreed to participate to their Transport Managers 
who will then schedule time for participating drivers to 
attend the baseline (and follow- up) measurements.
Within the UK logistics industry, 1% of HGV drivers 
are women,15 and the proportion of female HGV drivers 
employed by our partner company reflects this national 
average. While females will be included in the study, due 
to the small proportion of the workforce they represent, 
the included sample of females may not enable statisti-
cally meaningful comparisons to examine any influences 
of sex on the intervention. However, the sample recruited 
will likely reflect the gender disparities seen in the logis-
tics and transport industry nationally and internationally.
Sample size
Our earlier exploratory pre- post study revealed that on 
average HGV drivers achieve 8786 steps/day across both 
workdays and non- workdays with a SD of 2919 steps.20 
We have powered this study to look for a difference in 
step counts (the primary outcome) of 1500 steps/day 
(equivalent to approximately 15 min of moderately 
paced walking) between the intervention group and 
control group. Evidence demonstrates a linear associa-
tion between step counts and a range of morbidity and 
mortality outcomes, as well as with markers of health 
status including inflammation and adiposity, insulin sensi-
tivity and HDL- C in adults.24–26 The linear association 
between step counts and health outcomes indicate that 
regardless of an individual’s baseline value, even modest 
increases in daily step counts can yield clinically mean-
ingful health benefits. For example, a difference in daily 
steps of 1500 steps/day has been associated with around 
a 5%–10% lower risk of all- cause mortality and cardiovas-
cular morbidity and mortality in the general population 
and in those with a high risk of type two diabetes, respec-
tively.27 28 The proposed level of change has been chosen 
based on findings from our exploratory pre- post interven-
tion,20 while also being clinically meaningful.
Based on a cluster size of 10, a conservative ICC of 0.05 
(as there is no previous data to inform this, we have been 
informed by recommendations of Campbell et al29), an 
alpha of 0.05, power of 80% and a coefficient of varia-
tion to allow for variation in cluster size of 0.51 (based 
on partner company data), we will require 110 partic-
ipants from 11 clusters per arm. From experience in 
conducting such studies, it is estimated that retention and 
compliance rates will be approximately 70% at 12 months 
follow- up; therefore, the sample size will be inflated by 
30% to ensure we have adequate power in our final anal-
ysis. We will also inflate the number of clusters by two to 
allow for whole cluster drop out. We will therefore recruit 
24 clusters with an average of 14 participants per cluster.
Intervention—the ShIFT programme
The SHIFT programme is a multicomponent lifestyle- 
behaviour intervention designed to target behaviour 
changes in physical activity, diet and sitting in HGV 
drivers. This 6- month intervention, grounded within 
the Social Cognitive Theory for behaviour change30 
consists of a group- based (four to six participants) 6- hour 
structured education session tailored for HGV drivers, 
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Figure 1 Trial design and participant flow through the study.
Pilkington Library. Protected by copyright.
 o
n
 D
ecem
ber 16, 2019 at Loughborough University/The
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030175 on 24 November 2019. Downloaded from 
5Clemes SA, et al. BMJ Open 2019;9:e030175. doi:10.1136/bmjopen-2019-030175
Open access
Table 1 Outline of the educational component of the SHIFT programme
Section name Theoretical underpinning Main aims and educator activities Duration (min)
Welcome and introduction Participants introduced to the SHIFT programme and 
made aware of both content and style of the session.
10
Driver story Dual process theory,74 
common sense model75
Participants asked about their beliefs about how being 
a HGV driver can affect health, the causes of these 
health problems and controllability of these.
30
Risks and health problems Dual process theory,74 
common sense model,75 
social learning theory76
Facilitator uses participant stories to support them 
to work out why they may be at risk of future health 
problems, and what to do to reduce/manage risk.
55
Physical activity Dual process theory,74 
social learning theory76
Facilitator supports participants to develop knowledge 
and skills to support confidence to increase personal 
activity levels, to set personal goals and self- monitor 
through the use of Fitbits. Introduction and practical 
demonstration of the ‘cab- workout’.
80
Depression, sleeping, 
smoking
Dual process theory,74 
social learning theory76
Facilitator supports participants to develop strategies to 
manage depression, poor sleep and smoking.
30
Food choices Dual process theory,74 
social learning theory76
Facilitator supports participants to develop knowledge 
and skills for food choices to reduce cardiovascular risk 
factors and improve overall health.
90
Self- management plan Dual process theory,74 
social learning theory76
Participants supported in developing personal self- 
management plans.
15
Questions Common sense model,75 
social learning theory76
Facilitator checks all questions raised by participants 
throughout the programme have been answered and 
understood.
5
What happens next Social learning theory76 Follow- up care outlined. 5
HGV, heavy goods vehicle; SHIFT, Structured Health Intervention For Truckers.
delivered by two trained educators. It includes infor-
mation about physical activity, diet and sitting and risk 
factors for type 2 diabetes and cardiovascular disease. 
The educational component is founded on the approach 
used in the award winning suite of Diabetes Education 
and Self- Management for Ongoing and Newly Diag-
nosed programme (DESMOND) programmes, including 
the Prediabetes Risk Education and Physical Activity 
Recommendation and Encouragement programme 
(PREPARE)31 and Let’s Prevent Diabetes programmes,32 
created by researchers at the Leicester Diabetes Centre 
and used throughout the National Health Service 
(NHS),33 while being tailored to meet the needs of HGV 
drivers.7 Within the education session participants will 
not be ‘taught’ in a formal way, but supported to work 
out knowledge through group discussions and to develop 
individual goals and plans, based on detailed individual 
feedback received during their health assessments (see 
‘Measurements’ section) to achieve over the 6- month 
intervention period. The education session is supported 
by specially developed resources for HGV drivers and 
participant support materials. The session will include the 
discussion of feasible strategies for participants to increase 
their physical activity, improve their diet and reduce their 
sitting time (when not driving) during working and non- 
working hours. The content of the educational session is 
summarised in table 1.
During the education session, participants will be 
provided with a Fitbit Charge 2 activity tracker and 
encouraged to use this to set goals (agreed at the session) 
to gradually increase their physical activity predominately 
through walking- based activity. The Fitbit activity tracker 
will provide participants with information on their daily 
step counts and will be used as a tool for self- monitoring 
and self- regulation. Physical activity tracking using step 
counters (traditionally pedometers) has been associated 
with significant reductions in BMI and blood pressure, 
with interventions incorporating goal setting being the 
most effective.34
The education session will adopt the promotion of the 
‘small changes’ philosophy using the Specific, Measurable, 
Attainable, Relevant, and Timely (SMART) principle35 to 
encourage participants to gradually build- up their daily 
activity levels, within the confines of their occupation, to 
meet the current UK Physical Activity guidelines.36 For 
example, participants will be encouraged to establish their 
own personalised action plan, which may also include 
making dietary improvements in addition to increases 
in physical activity, with SMART goals throughout the 
6- month intervention. ‘Step count challenges’ (1 week 
competitions within intervention depots) will run every 6 
weeks throughout the 6- month intervention which will be 
facilitated by local worksite champions. A ‘cab workout’ 
will be introduced and practised at the education session 
and participants will be provided with resistance bands 
and balls, and grip strength dynamometers to take away. 
Participants will be encouraged to undertake the cab 
workout during breaks when not permitted to leave their 
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Figure 2 Logic model for the Structured Health Intervention For Truckers (SHIFT) intervention. BMI, body mass index; CPC, 
continued professional competence; PA, physical activity.
vehicle. Participants will be able to keep the intervention 
tools beyond the 6- month intervention period, however 
the company will choose whether to sustain the worksite 
champion support and step count challenges beyond the 
6- month intervention period. A logic model detailing the 
underlying theory behind the intervention components 
is shown in figure 2.
The structured education session will be delivered by 
trained personnel from our partner company and by 
trained members of the research team. These individuals 
will be trained and mentored by trainers from the Leicester 
Diabetes Centre. The education sessions will take place 
within appropriate training rooms within the interven-
tion depots. Personnel delivering the education sessions 
within each intervention depot will also be trained to act 
as a local champion, shown to enhance the effectiveness of 
worksite physical activity interventions.37 They will provide 
ongoing health coach support to intervention participants 
(during the 6- month intervention period) and be respon-
sible for facilitating the step count challenges.
Control arm
Depots assigned to the usual practice control arm will 
be asked to continue with their usual care conditions. 
Participants in the control depots will receive an educa-
tional leaflet at the outset detailing the importance of 
healthy lifestyle behaviours (ie, undertaking regular phys-
ical activity, breaking up periods of prolonged sitting and 
consuming a healthy diet) for the promotion of health 
and well- being. Control participants will be requested 
to complete the same study measurements as those in 
the intervention worksites, at the same time points. On 
completion of the study, control depots will be provided 
with all of the educational material provided to the inter-
vention participants as part of the SHIFT programme. As 
the intervention will be delivered by trained personnel 
within our partner company, the company may choose 
to provide the full intervention (including the education 
session and health coach support) to control depots on 
completion of the formal trial.
Allocation to treatment groups
Clusters (depots within the same company) will be 
randomised at the worksite level into the two study arms 
(intervention and control, using an allocation ratio of 
1:1). Randomisation into the study arms will take place in 
two batches; initially the first six clusters (depots) involved 
in the internal pilot (see below) will be randomised, and 
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in the second batch all of the remaining clusters will be 
randomised stratified by depot size. Depots will be classi-
fied as either small or large based on the median cluster 
size of all participating depots. In both batches randomi-
sation will take place on completion of baseline measure-
ments and will be done by an independent statistician at 
the Leicester Clinical Trials Unit.
Measurements
The outcome measurements will be assessed at three time 
points. Baseline measures will occur prior to randomisa-
tion of the depots into the two study arms. A second set of 
identical measurements will take place 6 months postran-
domisation (ie, just after the completion of the 6- month 
intervention), and a final set will be taken at 12 months 
postrandomisation to assess the sustainability of the inter-
vention (ie, 6 months after completion of the formal inter-
vention period, as recommended by the National Obesity 
Observatory).38 At the baseline assessment, the study will 
be explained to the participant and written informed 
consent will be obtained. The measurements will be 
undertaken in suitable rooms within participating depots 
by trained researchers and will last between 1.5 and 2 
hours per participant. Participants will complete a range 
of self- report questionnaires and have a series of physi-
ological health assessments taken. All participants will 
receive detailed feedback on their physiological health 
assessment measures during each measurement session. 
In the event that a potential health issue is evident during 
the health assessments, such as undiagnosed hyperten-
sion or high cholesterol levels, participants will be advised 
to visit their GP for further checks. We will provide partic-
ipants with a letter to give to their GP which summarises 
the findings from our point- of- care (blood markers) 
and automated (blood pressure) measures. Participants 
will be requested to inform the researchers about the 
use of any prescribed medications that they commence 
throughout the study duration which may impact the 
proposed outcome measures. Participants will be issued 
with objective monitoring devices to assess their free- 
living physical activity, sedentary behaviour and sleep, 
which they will be instructed to wear for 8 days following 
each measurement visit. After 8 days, participants will be 
requested to return these monitors to their depot where 
they will be collected by a member of the research team.
Primary outcome
The primary outcome will be physical activity, expressed 
as steps/day, at 12 months postrandomisation. Physical 
activity will be objectively measured using the activPAL 
microaccelerometer, worn continuously on the ante-
rior aspect of the thigh, for 24 hours/day over 8 days 
during each assessment period. The activPAL provides 
a valid measure of walking and posture (ie, sitting and 
standing) in adults,39–41 and provides a more accurate 
measure of physical activity and sitting in occupational 
drivers in comparison to waist- worn accelerometers.42 
As the physical activity component of the intervention 
predominantly includes the promotion of walking- based 
activity, and as participants will be provided with a Fitbit 
providing information on daily step counts to set goals to 
increase their physical activity, steps/day was chosen as 
the primary physical activity- related outcome.
Secondary outcomes
A number of secondary outcomes will be assessed at all 
measurement time points. The secondary outcomes are 
described as follows:
 Physical activity and sedentary behaviour
Light physical activity and MVPA will be assessed using the 
activPAL and the wrist- worn GENEActiv accelerometer, 
both worn continuously for 8 days. The GENEActiv is a 
lightweight waterproof device, resembling a sports watch, 
which has been found to be a valid and reliable objective 
measure of physical activity.43 Outcomes calculated from 
the GENEActiv include minutes spent in MVPA, propor-
tion of participants meeting the MVPA guidelines of 150 
min/week, total volume of physical activity regardless of 
intensity, and sleep duration. The accelerometer provides 
time- stamped data so activity at specific times of the day 
(eg, during work, after work) will also be extracted.
Sedentary behaviour will also be measured for eight 
consecutive days during each assessment period using the 
activPAL3 micro. The activPAL is regarded as the most 
accurate method of assessing sitting behaviour in free- 
living settings,41 44 45 and is recommended for use in inter-
ventions when sitting is an outcome measure.40 From the 
data provided, we will extract total daily sitting time, work- 
time and leisure- time sitting, sitting bout durations and 
number of transitions between sitting and standing.
 Sleep duration, subjective sleepiness and chronotype
Sleep duration and efficiency will be measured objec-
tively using the GENEActiv which has been shown to 
be an accurate measure of sleep, in addition to physical 
activity.46 Subjective sleepiness will be assessed using the 
Karolinska Sleepiness Scale, shown to be a valid measure 
of sleepiness when validated against electroencephalog-
raphy and performance outcomes.47 48 Participants’ chro-
notype will be determined using the short version of the 
Morningness- Eveningness Questionnaire.49
 Anthropometry, adiposity and blood pressure
Stature (measured at baseline only) and body mass (both 
assessed without shoes), along with waist and hip circum-
ferences, will be measured using standardised anthropo-
metric techniques by trained research staff. BMI will be 
calculated as weight (kg)/height (m2). Body composi-
tion (percentage body fat and fat mass) will be assessed 
via bioimpedance analysis, using Tanita DC- 360S body 
composition scales. We will also measure neck circum-
ference which is a novel marker which links strongly to 
obstructive sleep apnoea, insulin resistance and cardio-
vascular disease risk.50 Blood pressure will be measured 
from the left arm after a 20 min period of quiet sitting 
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using an automated recorder (Omron HEM-907), in 
accordance with current recommendations.51
 Biochemical assessments
Finger- prick blood samples will be collected from partic-
ipants, with participants being requested to fast for ≥4 
hours prior to attending each health assessment. The 
‘A1CNow+ point- of- care analyser will be used to measure 
HbA1c which is a marker of long- term glucose regula-
tion used in clinical care. Additionally, we will use the 
Cardiochek point- of- care analyser to measure circulating 
cholesterol (total, HDL, LDL). Both of these systems are 
manufactured by PTS Diagnostics and possess analyte 
validation certificates from the International Federation 
of Clinical Chemistry and Laboratory Medicine.
 Functional fitness
Grip strength will be assessed from both hands using the 
Takei Hand- Grip dynamometer (Takei Scientific Instru-
ments, Japan). Reduced muscular strength, as measured 
by grip strength, is associated with an increased risk of 
cardiovascular disease, and all- cause and cardiovascular 
mortality.52
 Cognitive function and psychophysiological reactivity
The Stroop test will be administered over a 5 min period 
using a validated software package to provide a measure of 
reaction time, sensitivity to interference and the ability to 
suppress an automated response—reading colour names 
in favour of naming the font colour.53 To examine psycho-
physiological reactivity, acute stress will be induced using 
a 5 min mirror- tracing task (Campden Instruments), 
during which measures of blood pressure and heart rate 
will be taken.54
 Work-related psychosocial variables and mental health
A series of self- report measures will be employed to 
characterise work- related health and mental health: 
musculoskeletal symptoms will be assessed using the 
Standardised Nordic Questionnaire55; work engagement 
(characterised by vigour, dedication and absorption) 
will be measured using the Utrecht Work Engagement 
Scale56; occupational fatigue will be measured using the 
Occupational Fatigue Exhaustion Recovery 15 scale57; job 
performance58 and job satisfaction59 will be measured 
using single- item 7- point Likert scales; sickness presen-
teeism will be assessed using a single- item questionnaire; 
participant’s perceptions of work demand and support 
will be assessed using four subscales from the Health 
and Safety Executive Management Standards Indicator 
Tool,60 and driving- related safety behaviour will be 
assessed using a 6- item measure.61 Anxiety and depres-
sion will be measured using the Hospital Anxiety and 
Depression Scale,62 and social isolation will be assessed 
using the 8- item Social Isolation short form from the 
Patient- Reported Outcomes Measurement Information 
System.63 64 Data on sickness absence will be collected 
via self- report and employer records and will include 
frequency and duration of self- certified and certified 
sickness. Data on sickness absence will be collected from 
organisational records for 12 months prior to the inter-
vention and for the 6- month intervention and follow- up 
periods.
 Health-related quality of life and health-related resource use
The self- reported EQ5D65 will be completed by partici-
pants during each assessment period to inform the within- 
trial cost- effectiveness analysis (see ‘Cost- effectiveness’ 
section). Participants will also complete a questionnaire, 
developed for this study, assessing health- related resource 
use at the same time points.
 Demographics and additional lifestyle health-related behaviour 
measures
At baseline we will collect basic demographic informa-
tion for each participant including their date of birth, 
sex, ethnicity, highest level of education, marital status, 
postcode (to determine Index of Multiple Deprivation as 
an indicator of neighbourhood socioeconomic status), 
working hours, years worked as a HGV driver and years 
worked at our partner company. At each follow- up assess-
ment, participants will be asked if there have been any 
changes in these variables. During each assessment, 
information on smoking status and typical alcohol intake 
will be gathered by self- report measures. Dietary quality, 
including fruit and vegetable intake, will be assessed using 
a short- form food frequency questionnaire.66
Internal pilot
We intend to conduct an internal pilot study using the 
first six clusters (depots). The internal pilot will examine 
issues surrounding worksite and participant recruitment, 
randomisation, compliance to the primary outcome and 
retention rates at 6 months following randomisation. 
After this period, we will continue to the full trial if the 
following progression criteria are met:
 ► All 24 depots required for the full sample size agree to 
take part in the study. Six depots will be selected to take 
part in the internal pilot (three will be randomised to 
the intervention arm and three to the control arm). 
This will demonstrate that depot recruitment and 
intervention delivery is on track.
 ► According to our criteria, 84 drivers will need to 
agree to participate in the internal pilot, based on an 
average of 14 participants per cluster.
 ► An average of 75% of drivers opting into the study, 
randomised into the intervention arm, attend the 
education session across the three intervention 
depots. This figure is based on the intervention 
uptake rate seen in our exploratory pre- post interven-
tion study (87%),20 while also recognising that take- up 
rates tend to be lower when moving from an efficacy 
to a larger multicentre effectiveness trial.
 ► No more than 20% of participants fail to provide valid 
data for the primary outcome measure (activPAL- 
determined step counts) at baseline and at 6 months 
postrandomisation or withdraw/are lost to follow- up 
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during the 6- month intervention phase. This 
threshold is necessary as study power requires total 
withdrawal or loss to follow- up of no higher than 
30% during the 6- month intervention and 6- month 
follow- up (12 months postrandomisation).
If the final two progression criteria are not fully met, 
strategies to improve these metrics for the full trial will 
be discussed with the Trial Steering Committee and the 
study will progress based on recommendations from this 
committee.
Process evaluation
The process evaluation will be used to help explain any 
discrepancies between expected and observed outcomes, 
to understand the influence of intervention components 
and context on the observed outcomes and to provide 
insight for any further intervention development and 
implementation.22 Throughout the intervention, we 
will monitor the reach, efficacy, adoption, implemen-
tation and maintenance of the intervention using the 
reach, efficacy, adoption, implementation, and mainte-
nance (RE- AIM) framework.67 We will employ a variety 
of techniques (eg, logbooks, questionnaires, interviews 
and focus groups) to inform our process evaluation. 
For example, Transport Managers (or their nominated 
facilitators) and educators/worksite champions from 
each site will report on a monthly basis if there were 
any organisational changes (eg, job changes) or events 
which may affect participation. Self- report questionnaires 
provided to study participants will evaluate the various 
intervention components (eg, education session, physical 
activity monitoring tool, cab workout). Interviews and 
focus groups with study participants will further examine 
engagement in the various components of the interven-
tion, along with any perceived barriers or facilitators to 
participating in these components. Interviews and focus 
groups with worksite champions, HR staff, health and 
safety personnel and logistics timetabling and planning 
staff will further examine the intervention implementa-
tion. We will also document any environmental factors 
(eg, movement of personnel between worksites/depots, 
potential contamination of the intervention through 
drivers in different groups meeting at service stations/
customer distribution centres) that may have an influ-
ence on intervention effectiveness. Details of the process 
evaluation components are included in table 2.
Patient and public involvement
This trial is the result of an earlier 3- year partnership 
between the research team and a large transport and 
logistics company (different to our partner in the present 
study) in the East Midlands, UK. The preparatory work 
which informed this study3 7 16 17 was instigated by the 
company who requested help in improving the lifestyle 
behaviours and health of their long- distance drivers who 
were proving difficult to engage. The SHIFT programme 
was developed in collaboration with long- distance HGV 
drivers and health and safety personnel working within 
the logistics sector. Following pilot testing, the inter-
vention and outcome measures described within this 
protocol have been refined following further input 
from drivers and associated stakeholders. A driver and 
manager working within the logistics sector will sit on our 
independent Trial Steering Committee and will provide 
invaluable insight into the design, set- up, conduct and 
dissemination of this research. Throughout the trial, 
we will conduct regular patient and public involvement 
events with relevant stakeholders to gain feedback on the 
trial’s progress. The research team will also continue to 
work with the Chartered Institute of Logistics and Trans-
port to facilitate research dissemination (articles, confer-
ences, workshops) across the logistics and transport sector 
nationally and internationally.
data analysis
Statistical analysis: internal pilot
The average recruitment rate across depots, proportion of 
participants providing valid data and attendance rate at the 
education sessions will be reported with 95% CI. The point 
estimates and 95% CIs will be compared with the progres-
sion criteria outlined outlined in the Internal Pilot section
Statistical analysis: main trial
Average daily steps at 12 months will be compared by group 
using generalised estimating equation models adjusted for 
baseline values and waking wear time with an exchangeable 
correlation structure, which adjusts for clustering. For the 
primary analysis missing data will not be replaced (complete 
case analysis) but participants will be included in the interven-
tion group in which their depots were randomised irrespective 
of the intervention actually received (modified intention- to- 
treat analysis). We have inflated our sample size by 30% to 
account for potential loss to follow- up and non- compliance 
with the primary outcome measure. We will compare the 
baseline characteristics of those who have complete primary 
outcome data and those who do not. A sensitivity analysis 
using multiple imputation will be performed to assess the 
impact of missing outcome data on the results found and to 
account for uncertainty associated with imputing data (full 
intention- to- treat analysis). The imputation will be carried out 
using the command MI in Stata. MI replaces missing values 
with multiple sets of simulated values to complete the data, 
performs standard analysis on each completed dataset and 
adjusts the obtained parameter estimates for missing data 
uncertainty using Rubin’s rules to combine estimates. The 
effect size will also be assessed by attendance excluding those 
who did not attend the full intervention (per- protocol anal-
ysis). Secondary outcomes and 6month data will be analysed 
using similar methodology.
Qualitative analyses
Audio- recordings of interviews and focus groups with 
drivers, worksite champions, HR staff, health and safety 
personnel and logistics timetabling and planning staff will 
be transcribed verbatim and analysed using framework 
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Table 2 Process evaluation plan for the SHIFT intervention
Areas to measure General process questions
Data source and data collection 
method
Total numbers and sampling strategy/
timescales
Recruitment Number of depots/worksites invited to 
participate, and number agreeing.
Number of possible participants at each depot, 
number invited/recommended for participation, 
number opting in to the intervention.
Number of participants opting- out, dropping out 
and non- compliance to the primary outcome 
measure.
Project records, including the 
number of drivers within each depot 
approached.
Depot logs of staff numbers, project 
records, attendance records at 
measurements.
Participant attendance records, short 
questionnaires to explore reasons for 
non- participation, dropping out and 
non- compliance.
Ongoing throughout the project.
Acceptability of 
randomisation and 
measurement tools
How depots feel about being randomised to 
intervention/control arms?
Did participants find outcome assessments 
acceptable?
How did participants and logistics timetabling 
staff experience recruitment and timetabling of 
outcome assessments?
  Focus groups with participants.
  Interviews with local depot health 
and safety advisors/HR/timetabling 
staff.
~8 focus groups, or until data saturation is 
reached, with participants ~1 month following 
completion of baseline measures.
~8 interviews, or until data saturation is 
reached, with local depot health and safety 
advisors/HR/timetabling staff ~1 month after 
completion of baseline measures in their 
depots.
Intervention 
acceptability 
and fidelity—
implementation
Was the intervention implemented as planned?
How did participants and logistics timetabling 
staff experience scheduling the education 
sessions?
Interviews with personnel within our 
logistics partners who are trained 
as educators and implemented the 
education sessions.
Interviews with local worksite 
champions and timetabling staff 
within intervention depots.
Participant questionnaires.
Interviews with educators, the number of which 
will depend on the number of educators trained, 
and timetabling staff immediately following 
delivery of the education sessions.
Interviews with local champions 3 months 
into the intervention, immediately following 
the intervention (6 months), and at 9 and 12 
months.
Questionnaires administered after education 
sessions to participants.
Intervention 
acceptability and 
fidelity—participation
What proportion of the target group participated 
in the intervention, and what components of 
the intervention were preferred, did this differ 
between males and females?
What strategies were put in place by intervention 
participants to facilitate behaviour change?
Focus groups with intervention 
participants.
Attendance logs at education 
sessions and measurement visits.
Questionnaires and focus groups.
~8 focus groups, or until data saturation is 
reached, with participants immediately following 
completion of the intervention (6 months).
Brief questionnaires administered to all 
intervention participants at 6 months during 
health assessments.
Intervention 
sustainability
What proportion of the target group maintained 
any changes in their health behaviours following 
the 6- month intervention period?
Were there any differences in sustainability 
between males and females?
Are the company going to continue with the 
intervention in some way?
Focus groups with intervention 
participants.
Questionnaires.
Interviews with health and safety 
personnel.
~8 focus groups, or until data saturation 
is reached, with participants at 10 months 
follow- up (4 months after completion of the 
intervention).
Brief questionnaires administered to all 
intervention participants at 12 months during 
health assessments.
Interviews at 12 months.
Intervention 
contamination
Did movement of staff (eg, participants, health 
and safety personnel) occur from intervention to 
control depots?
Did intervention drivers interact with control 
drivers at customer warehouses/distribution 
centres, etc?
Control depots to keep a log of any 
staff changes.
Focus groups with intervention and 
control participants.
Logs collected on completion of the 12- month 
follow- up assessments.
8 focus groups, or until data saturation 
is reached, with intervention and control 
participants immediately following completion 
of the intervention (6 months) and at 10 months 
follow- up.
Unexpected events 
arising from the study
Did intervention and control participants modify 
their behaviours based on information provided at 
the baseline health assessments?
Did the health assessments prompt general 
practitioner visits?
Did increased self- awareness of health status 
and constraints within the job lead to cognitive 
dissonance?
Did intervention participants change an existing 
activity- related behaviour for another as a result 
of participating in the study?
Focus groups, interviews and 
questionnaires delivered to 
intervention and control participants.
Questionnaires delivered to intervention and 
control participants 1 month after completion of 
the baseline health assessments.
8 focus groups, or until data saturation 
is reached, with intervention and control 
participants immediately following completion 
of the intervention (6 months) and at 10 months 
follow- up.
One- to- one interviews based on questionnaire 
and focus group responses at 1 and 10 months.
analysis,68 69 using the RE- AIM framework67 as the overar-
ching framework.
Cost-effectiveness
The economic analysis will consist of a cost- consequence 
analysis based on the observed results within the trial 
period and a cost- effectiveness analysis where differences 
between groups in the trial will be extrapolated to the 
longer term. For both analyses, costs in both arms will 
be estimated from a NHS and Personal Social Services 
perspective (consistent with that used by the National 
Institute for Health and Care Excellence) as well as a 
wider public sector perspective. In each analysis, the cost 
of the SHIFT arm will include an estimate of the cost of 
the intervention (including the cost of training the educa-
tors), generated through a staff questionnaire completed 
at the end of each education session.
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Within-trial analysis
Within the trial, resource use estimates will be collected 
from participant questionnaires and will include health- 
related resource use as well as absence from employ-
ment. The health- related resource use will be based on 
a variant of the Client Service Receipt Inventory and will 
include services that this population are likely to use 
such as GPs and practice nurse appointments, occupa-
tional health visitors and counsellors. Costs of resources 
will be calculated by applying published national unit 
cost estimates (eg, NHS reference costs or Personal 
Social Services Research Unit costs of health and social 
care),70 71 where available, to estimates of relevant 
resource use.
A range of outcomes will be assessed in the trial 
including health- related quality of life, measured using 
the EQ5D.65 The within- trial analysis will present incre-
mental results for the primary and secondary outcomes 
(including EQ5D) in both intervention and control 
arms and will be compared with the incremental costs 
measured. We will also present the results in terms of the 
differences between the groups in time absent from work. 
Two analyses will be conducted, one including these 
productivity losses, the other excluding them. This will 
allow decision makers to assess the importance of inclu-
sion of these costs in the adoption decision.
Long-term analysis
It is acknowledged that although there may be short- term 
health benefits from the intervention, the long- term effects 
of, for example, increased physical activity on diabetic 
status and number of cardiovascular events may be more 
important. We will therefore conduct a brief literature 
review to identify existing models that link short- term 
end points (including physical activity) measured in the 
trial and long- term quality of life. We have identified and 
used existing models72 linking physical activity to quality- 
adjusted life years (QALYs) previously. These models will 
be used to extrapolate costs and effects of the interven-
tion beyond the trial period to a more appropriate time 
horizon. If appropriate an incremental cost- effectiveness 
ratio for the extrapolated period will be reported using 
the QALY. As with the within- trial analysis, we will conduct 
analyses where productivity losses are included/excluded 
to assess the impact on decision making. Costs and effects 
will be discounted at the prevailing recommended rate 
(currently 1.5% per annum on both costs and effects), 
but will be the subject of sensitivity analysis to reflect the 
ongoing uncertainty around appropriate discount rates 
for public health interventions. To reflect the levels of 
uncertainty in parameter inputs we will conduct probabi-
listic sensitivity analyses; this will allow a characterisation 
of the uncertainty around the adoption decision which 
we will depict using cost- effectiveness acceptability curves. 
Sensitivity analyses will be performed to determine the 
robustness of the results to altering certain assumptions 
such as the discount rate or inclusion/exclusion of 
productivity losses.
dISCuSSIon
HGV drivers’ working environments are not conducive to 
a healthy lifestyle, despite this they are currently an under-
served occupational group in terms of health promotion 
efforts and exhibit higher than nationally representative 
rates of obesity and related comorbidities.10 17 The health 
and well- being of professional drivers is of public concern 
given their health impacts the safety of all road users.5 17 
Of concern, obese HGV drivers are approximately 50% 
more likely to have an accident than normal weight 
drivers,73 with accident rates increasing further in HGV 
drivers suffering from obstructive sleep apnoea, a preva-
lent condition in this occupational group.8 The present 
study will target health- related behaviours of this at- risk 
and underserved occupational group, with the goal of 
making a positive long- term impact on long- distance HGV 
drivers’ health. Given the current absence of resources 
available to tackle health inequalities within the trans-
port sector, it is anticipated that if effective, the SHIFT 
programme could be scalable as a Continued Professional 
Competence resource for HGV drivers nationally and 
internationally. This resource will likely be modifiable for 
use across other driving- related occupations. This could 
have a long- term impact on professional drivers’ health, 
lead to cost savings within the logistics and transport 
sector and ultimately impact road safety for all road users.
To our knowledge, this is the first RCT to examine the 
impact of a multicomponent intervention targeting indi-
vidual and environmental barriers faced by HGV drivers 
to lead a healthy lifestyle. Strengths of the study include 
the robust RCT design, with randomisation at the depot/
cluster level to reduce contamination. The large fully 
powered sample, objectively derived outcome measures 
and 6month follow- up assessment after completion of the 
SHIFT programme are further strengths, along with the 
extensive process and economic evaluations.
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